Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 2
2005 1
2007 2
2008 1
2009 1
2016 1
2017 1
2018 2
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Estrogen resistance syndrome"
Page 1
Polycystic ovaries and herbal remedies: A systematic review.
Manouchehri A, Abbaszadeh S, Ahmadi M, Nejad FK, Bahmani M, Dastyar N. Manouchehri A, et al. JBRA Assist Reprod. 2023 Mar 30;27(1):85-91. doi: 10.5935/1518-0557.20220024. JBRA Assist Reprod. 2023. PMID: 35916457 Free PMC article. Review.
OBJECTIVE: Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects one in every 15 women worldwide. This disorder is mainly characterized by increased levels of male hormones (androgens), acne, and hirsutism, and can lead to long-term insulin resistance …
OBJECTIVE: Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects one in every 15 women worldwide. This disorder is m …
Potential roles of genistein in polycystic ovary syndrome: A comprehensive systematic review.
Nasimi Doost Azgomi R, Moini Jazani A, Karimi A, Pourreza S. Nasimi Doost Azgomi R, et al. Eur J Pharmacol. 2022 Oct 15;933:175275. doi: 10.1016/j.ejphar.2022.175275. Epub 2022 Sep 13. Eur J Pharmacol. 2022. PMID: 36108737 Review.
Polycystic ovary syndrome (PCOS) is one of the most prevalent polygenic endocrine disorders in reproductive-age women. Genistein is a soy-isolated phytoestrogen and isoflavone with antioxidant, anti-inflammatory, estrogenic, and antineoplastic activity. This systema …
Polycystic ovary syndrome (PCOS) is one of the most prevalent polygenic endocrine disorders in reproductive-age women. Genistein is a …
Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis.
Zeng L, Yang K. Zeng L, et al. Endocrine. 2018 Jan;59(1):30-38. doi: 10.1007/s12020-017-1442-y. Epub 2017 Oct 19. Endocrine. 2018. PMID: 29052180 Review.
The primary outcomes included total testosterone, estradiol (E2) and the homeostatic model assessment (HOMA) of insulin resistance. RESULT: Ten trials involving 573 patients were included. ...CONCLUSION: Based on current evidence, myoinositol may be recommended for the tre …
The primary outcomes included total testosterone, estradiol (E2) and the homeostatic model assessment (HOMA) of insulin resistance. R …
Add-on effect of the Guizhi Fuling formula for management of reduced fertility potential in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Rong A, Ta N, E L, Meng W. Rong A, et al. Front Endocrinol (Lausanne). 2023 Apr 18;13:995106. doi: 10.3389/fendo.2022.995106. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 37143960 Free PMC article.
OBJECTIVE: To evaluate the add-on effect of the GZFL formula for treating reduced fertility potential in women with polycystic ovary syndrome (PCOS) by conducting a systematic review and meta-analysis. ...The secondary endpoints included the serum follicle-stimulating horm …
OBJECTIVE: To evaluate the add-on effect of the GZFL formula for treating reduced fertility potential in women with polycystic ovary synd …
Phytoestrogens in clinical practice: a review of the literature.
Tempfer CB, Bentz EK, Leodolter S, Tscherne G, Reuss F, Cross HS, Huber JC. Tempfer CB, et al. Fertil Steril. 2007 Jun;87(6):1243-9. doi: 10.1016/j.fertnstert.2007.01.120. Epub 2007 May 9. Fertil Steril. 2007. PMID: 17490659 Review.
OBJECTIVE: To review clinical studies assessing the effect of phytoestrogen supplementation on the signs and symptoms of the climacteric syndrome and on the incidence of breast cancer, cardiovascular disease, and skeletal fractures. ...RCTs document beneficial effects of p …
OBJECTIVE: To review clinical studies assessing the effect of phytoestrogen supplementation on the signs and symptoms of the climacteric …
Relationship between metabolic syndrome and follicle-stimulating hormone in postmenopausal women.
Lee SW, Hwang IS, Jung G, Kang HJ, Chung YH. Lee SW, et al. Medicine (Baltimore). 2022 May 6;101(18):e29216. doi: 10.1097/MD.0000000000029216. Medicine (Baltimore). 2022. PMID: 35550473 Free PMC article.
Depletion of ovarian reserve during menopausal transition raises follicle-stimulating hormone (FSH) markedly and menopause is related to an increased risk for metabolic syndrome (MetS). This study examined the relationship between FSH and MetS in postmenopausal women.We ev …
Depletion of ovarian reserve during menopausal transition raises follicle-stimulating hormone (FSH) markedly and menopause is related to an …
The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
Jing Z, Liang-Zhi X, Tai-Xiang W, Ying T, Yu-Jian J. Jing Z, et al. Gynecol Endocrinol. 2008 Oct;24(10):590-600. doi: 10.1080/09513590802288242. Gynecol Endocrinol. 2008. PMID: 19012104 Review.
OBJECTIVES: To systematically evaluate the efficacy and safety of Diane-35 for treating polycystic ovary syndrome (PCOS) and compare it with metformin, either in combination or alone. ...Whether Diane-35 deteriorates lipid metabolism and insulin resistance is still …
OBJECTIVES: To systematically evaluate the efficacy and safety of Diane-35 for treating polycystic ovary syndrome (PCOS) and compare …
Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease.
Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Regitz-Zagrosek V, et al. Gend Med. 2007;4 Suppl B:S162-77. doi: 10.1016/s1550-8579(07)80056-8. Gend Med. 2007. PMID: 18156101 Review.
METHODS: Using the search terms women, men, sex, gender, sex differences, and gender differences in combination with the metabolic syndrome, we conducted a systematic review of the available literature on sex differences in the MetS. ...Based on the definition of impaired …
METHODS: Using the search terms women, men, sex, gender, sex differences, and gender differences in combination with the metabolic syndro …
Testosterone a key factor in gender related metabolic syndrome.
Bianchi VE, Locatelli V. Bianchi VE, et al. Obes Rev. 2018 Apr;19(4):557-575. doi: 10.1111/obr.12633. Epub 2018 Jan 21. Obes Rev. 2018. PMID: 29356299
Metabolic syndrome (MetS) is highly correlated with cardiovascular diseases. ...We found 19 studies on the correlation between testosterone level with insulin resistance and 18 on the effect of testosterone therapy on MetS. A high correlation between low testosteron …
Metabolic syndrome (MetS) is highly correlated with cardiovascular diseases. ...We found 19 studies on the correlation between testos …
Clomiphene and anti-oestrogens for ovulation induction in PCOS.
Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E. Brown J, et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002249. doi: 10.1002/14651858.CD002249.pub4. Cochrane Database Syst Rev. 2009. PMID: 19821295 Updated. Review.
BACKGROUND: Subfertility due to anovulation is a common problem in women. First-line oral treatment is with anti-oestrogens, for example clomiphene citrate, but resistance (failure to ovulate) may be apparent with clomiphene. ...OBJECTIVES: To determine the relative …
BACKGROUND: Subfertility due to anovulation is a common problem in women. First-line oral treatment is with anti-oestrogens, for exam …
16 results